How a Rare Spinal Case Strengthens Zydus Lifesciences' Hospital Edge

A 35-year-old woman with a spinal tumor at L2 survived a rare post-surgical brain hemorrhage at Zydus Hospital in Ahmedabad, according to a June 26 press release from the hospital. The surgical team removed a 2x1.5 cm paraganglioma – a highly vascular neuroendocrine tumor – under intraoperative neuromonitoring. Within hours, the patient developed seizures and hypertensive spikes. Imaging showed intracranial bleeding and trapped air. The team diagnosed posterior reversible encephalopathy syndrome (PRES), a neurovascular disorder that occurs when rapid blood pressure surges overwhelm the brain's autoregulation. A decompressive craniectomy relieved the pressure. The patient required ventilator support but recovered.

For investors tracking Zydus Lifesciences (NSE: ZYDUSLIFE), the case is not a financial event. It is a signal about the hospital division's clinical depth. PRES is rare. Diagnosing and managing it requires coordinated neurology and radiology teams. The hospital documented the use of intraoperative neuromonitoring, repeat CT and MRI, and a planned 3D-printed titanium cranioplasty – all markers of advanced infrastructure.